Sandhofer Str. 116
68305 Mannheim, de
+49 (8856) 60-4830
Roche Announces Thomas Schinecker as New President of 454 Life Sciences
Dr. Schinecker is currently the Diagnostics General Manager of Sweden, located in Bromma, a suburb of Stockholm. Dr. Schinecker's extensive background and experience of over eight years at Roche will be instrumental in guiding 454 Life Sciences into the next generation of pyrosequencing. Dr. Schinecker holds a PhD in oncology, studying at the New York University. He then excelled in several leadership positions in the Sales & Marketing organization of Roche Diagnostics Austria, starting his career at Roche in the Perspectives Program in 2003. With his success in several key management positions within Roche Diagnostics, Dr. Schinecker brings the required organizational and operating skills to 454 Life Sciences' highly innovative and accurate long sequence read technology. 454 Sequencing Systems are used productively by large numbers of life science researchers in cancer, infectious disease, immunogenetics, drug discovery, agriculture and other disciplines, resulting in more than 1,000 peer-reviewed publications.
"We are very excited to announce Dr. Thomas Schinecker as new President of 454 Life Sciences, and look forward to expanding Roche's sequencing position as a leading genomics solution provider," stated Robert Yates, Head of Roche Applied Science. "Thomas's extensive experience in oncology and diagnostics make him the perfect guide for 454 Life Sciences' future development.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.